Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Protein Engineering Market, by Product
1.4.2 Europe Protein Engineering Market, by End-use
1.4.3 Europe Protein Engineering Market, by Technology
1.4.4 Europe Protein Engineering Market, by Protein Type
1.4.5 Europe Protein Engineering Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Europe Protein Engineering Market by Product
4.1 Europe Instruments Market by Country
4.2 Europe Reagents Market by Country
4.3 Europe Software & Services Market by Country
Chapter 5. Europe Protein Engineering Market by End-use
5.1 Europe Pharmaceutical & Biotechnology Companies Market by Country
5.2 Europe Contract Research Organizations (CROs) Market by Country
5.3 Europe Academic Research Institutes Market by Country
Chapter 6. Europe Protein Engineering Market by Technology
6.1 Europe Rational Protein Design Market by Country
6.2 Europe Hybrid Approach Market by Country
6.3 Europe Directed Evolution Market by Country
6.4 Europe De Novo Protein Design Market by Country
6.5 Europe Others Market by Country
Chapter 7. Europe Protein Engineering Market by Protein Type
7.1 Europe Monoclonal Antibodies Market by Country
7.2 Europe Insulin Market by Country
7.3 Europe Vaccines Market by Country
7.4 Europe Growth Factors Market by Country
7.5 Europe Interferon Market by Country
7.6 Europe Colony Stimulating Factors Market by Country
7.7 Europe Coagulation Factors Market by Country
7.8 Europe Others Market by Country
Chapter 8. Europe Protein Engineering Market by Country
8.1 Germany Protein Engineering Market
8.1.1 Germany Protein Engineering Market by Product
8.1.2 Germany Protein Engineering Market by End-use
8.1.3 Germany Protein Engineering Market by Technology
8.1.4 Germany Protein Engineering Market by Protein Type
8.2 UK Protein Engineering Market
8.2.1 UK Protein Engineering Market by Product
8.2.2 UK Protein Engineering Market by End-use
8.2.3 UK Protein Engineering Market by Technology
8.2.4 UK Protein Engineering Market by Protein Type
8.3 France Protein Engineering Market
8.3.1 France Protein Engineering Market by Product
8.3.2 France Protein Engineering Market by End-use
8.3.3 France Protein Engineering Market by Technology
8.3.4 France Protein Engineering Market by Protein Type
8.4 Russia Protein Engineering Market
8.4.1 Russia Protein Engineering Market by Product
8.4.2 Russia Protein Engineering Market by End-use
8.4.3 Russia Protein Engineering Market by Technology
8.4.4 Russia Protein Engineering Market by Protein Type
8.5 Spain Protein Engineering Market
8.5.1 Spain Protein Engineering Market by Product
8.5.2 Spain Protein Engineering Market by End-use
8.5.3 Spain Protein Engineering Market by Technology
8.5.4 Spain Protein Engineering Market by Protein Type
8.6 Italy Protein Engineering Market
8.6.1 Italy Protein Engineering Market by Product
8.6.2 Italy Protein Engineering Market by End-use
8.6.3 Italy Protein Engineering Market by Technology
8.6.4 Italy Protein Engineering Market by Protein Type
8.7 Rest of Europe Protein Engineering Market
8.7.1 Rest of Europe Protein Engineering Market by Product
8.7.2 Rest of Europe Protein Engineering Market by End-use
8.7.3 Rest of Europe Protein Engineering Market by Technology
8.7.4 Rest of Europe Protein Engineering Market by Protein Type
Chapter 9. Company Profiles
9.1 Agilent Technologies, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 Bruker Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.2.6 SWOT Analysis
9.3 Thermo Fisher Scientific, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 Waters Corporation
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 SWOT Analysis
9.5 Bio-Rad laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 SWOT Analysis
9.6 Merck KGaA
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Acquisition and Mergers:
9.7.6 SWOT Analysis
9.8 Genscript Biotech Corporation
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional & Segmental Analysis
9.8.4 Research & Development Expenses
9.8.5 SWOT Analysis
9.9 Amgen, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 SWOT Analysis
9.10. Promega Corporation
9.10.1 Company Overview
9.10.2 SWOT Analysis
Unique Offerings 